- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03413111
Modified Double Wire Technique to Facilitate the Successful Cannulation
May 15, 2018 updated by: Yanglin Pan, Air Force Military Medical University, China
Modified Double Wire Technique to Facilitate the Successful Cannulation: Prospective Randomized Study
Selective cannulation is considered the most challenging step for most of Endoscopic retrograde cholangiopancreatography (ERCP).
Wire-guided cannulation is the standard technique for initial cannulation.
When meeting difficulty, double wire technique (DWT) is widely used.
With one guidewire occupying pancreatic duct (PD), the following cannulation of common bile duct (CBD) with a sphincterotome preloaded with another guidewire often becomes feasible.
However, because of the small opening of the papilla, sometimes it is technically challenging for the following cannulation of CBD with the sphincterotome and PD guidewire in the same working channel.
We hypothesized that a tiny cut of the opening of papilla, without the injury of pancreatic sphincter, may facilitate the success of DWT and shorten the overall cannulation time.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
130
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710032
- Recruiting
- Endoscopic center, Xijing Hospital of Digestive Diseases
-
Contact:
- Yanglin Pan, M.D.
- Phone Number: 86-29-84771536
- Email: panyanglin@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients aged 18-90 with native papilla;
- CBD as the targeted duct;
- Inadvertent PD cannulation more than twice;
- Selective biliary cannulation was not possible within 10 minutes or 5 attempts.
Exclusion Criteria:
- Contraindications of ERCP;
- Major or minor PD as the targeted duct;
- NK or transpancreatic precut before enrollment ;
- Surgically altered GI anatomy;
- Papillary carcinoma or stone impaction within papilla or fistula in papilla;
- Prior endoscopic sphincterotomy;
- Complete pancreas divisum;
- failure of pancreatic duct cannulation;
- Pregnant or breastfeeding women;
- Unwilling or inability to provide consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Modified double wire technique
A sphincterotome was used for standard wire-guided cannulation.
If the difficult biliary cannulation occurred and guidewire inadvertently entered PD, a tiny cut of opening, with the length of 5mm, was performed with the sphincterotome.
Then the guidewire was left in PD and the sphincterotome withdrew.
The same sphincterotome was re-inserted in the working channel alongside the first guidewire, another wire is used for wire-guided selective cannulation of CBD.
If the cannulation of CBD was not successful within 5 attempts, other cannulation techniques (e.g.
transpancreatic precut, needle knife (NK) precut or over-the stent precut) would be tried at the discretion of endoscopists.
A 5Fr, unflanged PD stent was placed before the ending of ERCP.
|
For experimental arm, a tiny cut of papilla orifice, with the length of 5mm, was performed by sphincterotome before the double wire cannulation.
|
|
No Intervention: Standard double wire technique
A sphincterotome was used for standard wire-guided cannulation.
If the difficult biliary cannulation occurred and guidewire inadvertently entered PD, the guidewire was left in PD and the sphincterotome withdrew.
The same sphincterotome was re-inserted in the working channel alongside the first guidewire, another wire is used for wire-guided selective cannulation of CBD.
If the cannulation of CBD was not successful within 5 attempts, other cannulation techniques (e.g.
transpancreatic precut, NK precut or over-the stent precut) would be tried at the discretion of endoscopists.
A 5Fr, unflanged PD stent was placed before the ending of ERCP.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success rate of double wire technique
Time Frame: 3 hours
|
the rate of successful cannulation of CBD for ≤5 attempts by using the sphincterotome alongside the PD guidewire.
|
3 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
cannulation time of double wire technique
Time Frame: 3 hours
|
the time taken from the touching of papilla by the sphincterotome alongside the PD guidewire to the successful cannulation of CBD
|
3 hours
|
|
Number of attempts for the successful CBD cannulation
Time Frame: 3 hours
|
3 hours
|
|
|
Overall cannulation success rate
Time Frame: 3 hours
|
3 hours
|
|
|
complication rates
Time Frame: 48 hours
|
48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 2, 2018
Primary Completion (Anticipated)
January 16, 2019
Study Completion (Anticipated)
February 16, 2019
Study Registration Dates
First Submitted
January 17, 2018
First Submitted That Met QC Criteria
January 22, 2018
First Posted (Actual)
January 29, 2018
Study Record Updates
Last Update Posted (Actual)
May 17, 2018
Last Update Submitted That Met QC Criteria
May 15, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- KY20180081-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endoscopic Retrograde Cholangiopancreatography
-
Beijing Friendship HospitalCompletedEndoscopic Retrograde CholangiopancreatographyChina
-
Indiana UniversityCompletedCholangiopancreatography, Endoscopic RetrogradeUnited States
-
Boston Scientific CorporationCompletedEndoscopic Retrograde CholangiopancreatographyUnited States, Netherlands
-
Helsinki University Central HospitalCompletedEndoscopic Retrograde CholangiopancreatographyFinland
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingEndoscopic Retrograde CholangiopancreatographyItaly
-
Kliniken Ludwigsburg-Bietigheim gGmbHNot yet recruitingCholangiopancreatography, Endoscopic Retrograde
-
Olympus Europe SE & Co. KGCompletedCholangiopancreatography, Endoscopic RetrogradeBelgium, Germany, Norway
-
Boston Scientific CorporationCompletedEndoscopic Retrograde CholangiopancreatographyUnited States
-
Helsinki University Central HospitalTurku University Hospital; Oulu University HospitalCompletedEndoscopic Retrograde CholangiopancreatographyFinland
-
University Hospital, LinkoepingCompletedEndoscopic Retrograde CholangiopancreatographySweden
Clinical Trials on Modified double wire technique
-
Puerta de Hierro University HospitalCarlos III Health InstituteUnknown
-
Subhas BanerjeeCompletedBiliary Obstruction | Biliary StonesUnited States
-
Istituto Clinico HumanitasNot yet recruiting
-
Duke UniversityCompletedEndoscopic Retrograde CholangiopancreatographyUnited States
-
Zagazig UniversityCompletedIncisional Hernia of Midline of Abdomen | Incisional Hernia of Midline of Upper Abdomen | Incisional Hernia of Midline of Lower AbdomenEgypt
-
Korea University Anam HospitalSeoul National University Hospital; Kyungpook National University Chilgok Hospital and other collaboratorsEnrolling by invitationRectal Cancer | Rectal Neoplasms | Rectal Neoplasms Malignant | Rectal Cancer SurgerySouth Korea
-
University Medicine GreifswaldDeutsche Arthrose-HilfeCompletedFracture of Metacarpal BoneGermany
-
Sana'a UniversityRecruitingMalocclusion; Displaced TeethYemen
-
Guangdong Provincial People's HospitalShenzhen People's Hospital; Kashgar 1st People's HospitalUnknownCoronary Artery DiseaseChina
-
Dalian UniversityCompletedCoronary Artery DiseaseChina